| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 286.31B | 284.55B | 273.98B | 275.01B | 236.16B | 175.46B |
| Gross Profit | 23.32B | 22.77B | 20.85B | 21.26B | 19.71B | 14.37B |
| EBITDA | 8.41B | 7.97B | 7.53B | 7.13B | 6.76B | 3.85B |
| Net Income | 6.05B | 6.02B | 6.48B | 6.20B | 4.02B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 168.56B | 171.14B | 172.87B | 163.74B | 152.09B | 115.92B |
| Cash, Cash Equivalents and Short-Term Investments | 4.72B | 3.91B | 3.17B | 3.35B | 2.94B | 2.43B |
| Total Debt | 29.73B | 32.20B | 28.82B | 32.80B | 31.98B | 15.55B |
| Total Liabilities | 99.72B | 102.69B | 107.66B | 107.64B | 101.15B | 68.28B |
| Stockholders Equity | 68.82B | 68.44B | 65.19B | 56.09B | 50.92B | 47.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.16B | 3.37B | -1.51B | -12.92B | 5.94B |
| Operating Cash Flow | 0.00 | 2.14B | 8.23B | 869.00M | -12.55B | 7.50B |
| Investing Cash Flow | 0.00 | -3.00B | -2.73B | 175.00M | -1.51B | -685.00M |
| Financing Cash Flow | 0.00 | 1.29B | -5.79B | -876.00M | 14.42B | -6.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥61.12B | 7.59 | ― | 4.12% | -4.02% | -13.89% | |
74 Outperform | ¥352.09B | 12.83 | ― | 3.26% | -7.72% | 99.39% | |
73 Outperform | ¥56.85B | 7.80 | ― | 3.53% | 1.12% | -6.72% | |
70 Outperform | ¥95.13B | 10.61 | ― | 3.70% | -2.70% | -15.73% | |
66 Neutral | ¥44.47B | 6.60 | ― | 6.27% | -6.54% | -28.89% | |
64 Neutral | ¥185.32B | 14.38 | 7.36% | 3.42% | -17.96% | -43.14% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |